ArticleFrontiers in medicine2021

Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.